Marex Group plc, a financial services platform provider company, provides liquidity, market access, and infrastructure services to clients in the energy, commodities, and financial markets. It operates through Clearing, Agency and Execution, Market Making, and Hedging and Investment Solutions segments. The company offers execution and clearing services in metals, agricultural products, energy and financial futures and options; liquidity and execution services for financial securities through trading desks that cover products, including foreign exchange, equities, fixed income, and others. It also operates as an agent to trade in OTC energy products using knowledge of the energy sector and relationships with clients for oil, power and gas, and shipping and freight products; and provides market-making services across commodities markets, such as metals, agricultural products, and energy markets. In addition, the company offers OTC traded hedging and customized OTC derivatives solutions; and risk management solutions across commodity markets comprising agriculture, metals, energy, and currency markets for trading houses, producers and consumers, and banks and distributors. Further, it engages in the structured notes business, which allows investors to build structured notes across asset classes, including commodities, equities, foreign exchange, and fixed-income products for private banks, independent asset managers, pension funds, and corporates. Additionally, it offers technology platforms, including Neon, a trading, risk, and data platform; and Agile, a commodity broking platform. The company operates in the United Kingdom, the United States, and internationally. Marex Group plc was incorporated in 2005 and is headquartered in London, the United Kingdom.

Marex Group plc Ordinary Shares

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Immuneering (IMRX), Revolution Medicines (RVMD) and ...

Analysts Offer Insights on Healthcare Companies: Immuneering (IMRX), Revolution Medicines (RVMD) and Sight Sciences (SGHT)

Amneal Pharmaceuticals ( ($AMRX) ) has shared an update. On August 3, 2026, Amneal Pharmaceuticals LLC and certain subsidiaries executed Amendment ...

Amneal Pharmaceuticals Reprices Term Loans to Reduce Interest

Amneal Pharmaceuticals ( ($AMRX) ) has shared an update. On July 31, 2026, Amneal Pharmaceuticals held a special meeting of stockholders at which h...

Amneal Stockholders Approve Kashiv BioSciences Acquisition Plans

Goldman Sachs analyst Salveen Richter maintained a Buy rating on Amneal Pharmaceuticals today and set a price target of $19.00. According to TipRan...

Goldman Sachs Reaffirms Their Buy Rating on Amneal Pharmaceuticals (AMRX)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Amneal Pharmaceuticals (AMRX), Alnylam Pharma (ALN...

Analysts Have Conflicting Sentiments on These Healthcare Companies: Amneal Pharmaceuticals (AMRX), Alnylam Pharma (ALNY) and Biogen (BIIB)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Trevi Therapeutics (TRVI), Amneal Pharmaceuticals (AMRX) and Eras...

Analysts Have Conflicting Sentiments on These Healthcare Companies: Trevi Therapeutics (TRVI), Amneal Pharmaceuticals (AMRX) and Erasca (ERAS)

Jefferies analyst maintained a Buy rating on Marex Group plc today and set a price target of $80.00. In a report released on July 15, Piper Sandler...

Jefferies Sticks to Its Buy Rating for Marex Group plc (MRX)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Immuneering (IMRX), Vera Therapeutics (VERA) and A...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	MRX	$60.81	-2.45%	661.31K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	MRX	$60.81	-2.5%	661.31K
3
4
5
6

MRX

MRX

Get Marex Group plc Ordinary Shares Data in Excel

Get Marex Group plc Ordinary Shares Data in Excel